Global Pediatric Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 20-Sep-2022
No. of pages: 138
Inquire Before Buying

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pediatric Vaccines manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Pediatric Vaccines market. Further, it explains the major drivers and regional dynamics of the global Pediatric Vaccines market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- GlaxoSmithKline

- Merck

- Pfizer

- Sanofi

- AstraZeneca

- Novartis

- Takeda Pharmaceutical

- Bavarian Nordic

- Baxter

- LG Life Sciences

- Lupin

- S K Chemicals

- Mitsubishi Tanabe Pharma

- Janssen

- Shenzhen Kangtai Biological Products

- Sinovac Biotech

- Bharat Biotech

- Crucell

- Dynavax

- Serum Institute of India

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Pediatric Vaccines Segment by Type

- Diphtheria

- Influenza

- Hepatitis

- Pneumococcal Diseases

- Meningococcal Diseases

- Others

Pediatric Vaccines Segment by Application

- Newborn

- Infant

- Child

- Dolescent

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Colombia

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pediatric Vaccines market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Pediatric Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Pediatric Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pediatric Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pediatric Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Pediatric Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Pediatric Vaccines sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including GlaxoSmithKline, Merck, Pfizer, Sanofi, AstraZeneca, Novartis, Takeda Pharmaceutical, Bavarian Nordic and Baxter, etc.

Global Pediatric Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Pediatric Vaccines Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Diphtheria
1.2.3 Influenza
1.2.4 Hepatitis
1.2.5 Pneumococcal Diseases
1.2.6 Meningococcal Diseases
1.2.7 Others
1.3 Market Segment by Application
1.3.1 Global Pediatric Vaccines Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Newborn
1.3.3 Infant
1.3.4 Child
1.3.5 Dolescent
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pediatric Vaccines Market Size (2017-2028)
2.1.1 Global Pediatric Vaccines Revenue (2017-2028)
2.1.2 Global Pediatric Vaccines Sales (2017-2028)
2.2 Global Pediatric Vaccines Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Pediatric Vaccines Sales by Regions (2017-2022)
2.2.2 Global Pediatric Vaccines Revenue by Regions (2017-2022)
2.3 Global Pediatric Vaccines Market Size Forecast by Region
2.3.1 Global Pediatric Vaccines Sales Forecast by Region (2023-2028)
2.3.2 Global Pediatric Vaccines Revenue Forecast by Region (2023-2028)
2.4 Global Top Pediatric Vaccines Regions (Countries) Ranking by Market Size
2.5 Pediatric Vaccines Market Dynamics
2.5.1 Pediatric Vaccines Market Trends
2.5.2 Pediatric Vaccines Market Drivers
2.5.3 Pediatric Vaccines Market Challenges
2.5.4 Pediatric Vaccines Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Pediatric Vaccines Manufacturers by Sales (2017-2022)
3.1.1 Global Pediatric Vaccines Sales by Manufacturers (2017-2022)
3.1.2 Global Pediatric Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Pediatric Vaccines Sales in 2021
3.2 Global Top Manufacturers Pediatric Vaccines by Revenue
3.2.1 Global Pediatric Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Top Pediatric Vaccines Manufacturers Covered: Ranking by Revenue
3.2.3 Global Pediatric Vaccines Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Pediatric Vaccines Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2021)
3.4 Global Pediatric Vaccines Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pediatric Vaccines Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pediatric Vaccines Market
3.7 Key Manufacturers Pediatric Vaccines Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pediatric Vaccines Market Size by Type
4.1 Global Pediatric Vaccines Historic Market Review by Type (2017-2022)
4.1.1 Global Pediatric Vaccines Sales Market Share by Type (2017-2022)
4.1.2 Global Pediatric Vaccines Revenue Market Share by Type (2017-2022)
4.1.3 Pediatric Vaccines Price by Type (2017-2022)
4.2 Global Pediatric Vaccines Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Pediatric Vaccines Sales Forecast by Type (2023-2028)
4.2.2 Global Pediatric Vaccines Revenue Forecast by Type (2023-2028)
4.2.3 Pediatric Vaccines Price Forecast by Type (2023-2028)
5 Global Pediatric Vaccines Market Size by Application
5.1 Global Pediatric Vaccines Historic Market Review by Application (2017-2022)
5.1.1 Global Pediatric Vaccines Sales Market Share by Application (2017-2022)
5.1.2 Global Pediatric Vaccines Revenue Market Share by Application (2017-2022)
5.1.3 Pediatric Vaccines Price by Application (2017-2022)
5.2 Global Pediatric Vaccines Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Pediatric Vaccines Sales Forecast by Application (2023-2028)
5.2.2 Global Pediatric Vaccines Revenue Forecast by Application (2023-2028)
5.2.3 Pediatric Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pediatric Vaccines Sales Breakdown by Company
6.1.1 North America Pediatric Vaccines Sales by Company (2017-2022)
6.1.2 North America Pediatric Vaccines Revenue by Company (2017-2022)
6.2 North America Pediatric Vaccines Market Size by Type
6.2.1 North America Pediatric Vaccines Sales by Type (2017-2028)
6.2.2 North America Pediatric Vaccines Revenue by Type (2017-2028)
6.3 North America Pediatric Vaccines Market Size by Application
6.3.1 North America Pediatric Vaccines Sales by Application (2017-2028)
6.3.2 North America Pediatric Vaccines Revenue by Application (2017-2028)
6.4 North America Pediatric Vaccines Market Size by Country
6.4.1 North America Pediatric Vaccines Sales by Country (2017-2028)
6.4.2 North America Pediatric Vaccines Revenue by Country (2017-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Pediatric Vaccines Sales Breakdown by Company
7.1.1 Europe Pediatric Vaccines Sales by Company (2017-2022)
7.1.2 Europe Pediatric Vaccines Revenue by Company (2017-2022)
7.2 Europe Pediatric Vaccines Market Size by Type
7.2.1 Europe Pediatric Vaccines Sales by Type (2017-2028)
7.2.2 Europe Pediatric Vaccines Revenue by Type (2017-2028)
7.3 Europe Pediatric Vaccines Market Size by Application
7.3.1 Europe Pediatric Vaccines Sales by Application (2017-2028)
7.3.2 Europe Pediatric Vaccines Revenue by Application (2017-2028)
7.4 Europe Pediatric Vaccines Market Size by Country
7.4.1 Europe Pediatric Vaccines Sales by Country (2017-2028)
7.4.2 Europe Pediatric Vaccines Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pediatric Vaccines Sales Breakdown by Company
8.1.1 Asia Pacific Pediatric Vaccines Sales by Company (2017-2022)
8.1.2 Asia Pacific Pediatric Vaccines Revenue by Company (2017-2022)
8.2 Asia Pacific Pediatric Vaccines Market Size by Type
8.2.1 Asia Pacific Pediatric Vaccines Sales by Type (2017-2028)
8.2.2 Asia Pacific Pediatric Vaccines Revenue by Type (2017-2028)
8.3 Asia Pacific Pediatric Vaccines Market Size by Application
8.3.1 Asia Pacific Pediatric Vaccines Sales by Application (2017-2028)
8.3.2 Asia Pacific Pediatric Vaccines Revenue by Application (2017-2028)
8.4 Asia Pacific Pediatric Vaccines Market Size by Region
8.4.1 Asia Pacific Pediatric Vaccines Sales by Region
8.4.2 Asia Pacific Pediatric Vaccines Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Pediatric Vaccines Sales Breakdown by Company
9.1.1 Latin America Pediatric Vaccines Sales by Company (2017-2022)
9.1.2 Latin America Pediatric Vaccines Revenue by Company (2017-2022)
9.2 Latin America Pediatric Vaccines Market Size by Type
9.2.1 Latin America Pediatric Vaccines Sales by Type (2017-2028)
9.2.2 Latin America Pediatric Vaccines Revenue by Type (2017-2028)
9.3 Latin America Pediatric Vaccines Market Size by Application
9.3.1 Latin America Pediatric Vaccines Sales by Application (2017-2028)
9.3.2 Latin America Pediatric Vaccines Revenue by Application (2017-2028)
9.4 Latin America Pediatric Vaccines Market Size by Country
9.4.1 Latin America Pediatric Vaccines Sales by Country (2017-2028)
9.4.2 Latin America Pediatric Vaccines Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
9.4.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Pediatric Vaccines Sales Breakdown by Company
10.1.1 Middle East and Africa Pediatric Vaccines Sales by Company (2017-2022)
10.1.2 Middle East and Africa Pediatric Vaccines Revenue by Company (2017-2022)
10.2 Middle East and Africa Pediatric Vaccines Market Size by Type
10.2.1 Middle East and Africa Pediatric Vaccines Sales by Type (2017-2028)
10.2.2 Middle East and Africa Pediatric Vaccines Revenue by Type (2017-2028)
10.3 Middle East and Africa Pediatric Vaccines Market Size by Application
10.3.1 Middle East and Africa Pediatric Vaccines Sales by Application (2017-2028)
10.3.2 Middle East and Africa Pediatric Vaccines Revenue by Application (2017-2028)
10.4 Middle East and Africa Pediatric Vaccines Market Size by Country
10.4.1 Middle East and Africa Pediatric Vaccines Sales by Country (2017-2028)
10.4.2 Middle East and Africa Pediatric Vaccines Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Corporation Information
11.1.2 GlaxoSmithKline Overview
11.1.3 GlaxoSmithKline Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 GlaxoSmithKline Pediatric Vaccines Products and Services
11.1.5 GlaxoSmithKline Pediatric Vaccines SWOT Analysis
11.1.6 GlaxoSmithKline Recent Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Merck Pediatric Vaccines Products and Services
11.2.5 Merck Pediatric Vaccines SWOT Analysis
11.2.6 Merck Recent Developments
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Overview
11.3.3 Pfizer Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Pfizer Pediatric Vaccines Products and Services
11.3.5 Pfizer Pediatric Vaccines SWOT Analysis
11.3.6 Pfizer Recent Developments
11.4 Sanofi
11.4.1 Sanofi Corporation Information
11.4.2 Sanofi Overview
11.4.3 Sanofi Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Sanofi Pediatric Vaccines Products and Services
11.4.5 Sanofi Pediatric Vaccines SWOT Analysis
11.4.6 Sanofi Recent Developments
11.5 AstraZeneca
11.5.1 AstraZeneca Corporation Information
11.5.2 AstraZeneca Overview
11.5.3 AstraZeneca Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 AstraZeneca Pediatric Vaccines Products and Services
11.5.5 AstraZeneca Pediatric Vaccines SWOT Analysis
11.5.6 AstraZeneca Recent Developments
11.6 Novartis
11.6.1 Novartis Corporation Information
11.6.2 Novartis Overview
11.6.3 Novartis Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 Novartis Pediatric Vaccines Products and Services
11.6.5 Novartis Pediatric Vaccines SWOT Analysis
11.6.6 Novartis Recent Developments
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Corporation Information
11.7.2 Takeda Pharmaceutical Overview
11.7.3 Takeda Pharmaceutical Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.7.4 Takeda Pharmaceutical Pediatric Vaccines Products and Services
11.7.5 Takeda Pharmaceutical Pediatric Vaccines SWOT Analysis
11.7.6 Takeda Pharmaceutical Recent Developments
11.8 Bavarian Nordic
11.8.1 Bavarian Nordic Corporation Information
11.8.2 Bavarian Nordic Overview
11.8.3 Bavarian Nordic Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.8.4 Bavarian Nordic Pediatric Vaccines Products and Services
11.8.5 Bavarian Nordic Pediatric Vaccines SWOT Analysis
11.8.6 Bavarian Nordic Recent Developments
11.9 Baxter
11.9.1 Baxter Corporation Information
11.9.2 Baxter Overview
11.9.3 Baxter Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.9.4 Baxter Pediatric Vaccines Products and Services
11.9.5 Baxter Pediatric Vaccines SWOT Analysis
11.9.6 Baxter Recent Developments
11.10 LG Life Sciences
11.10.1 LG Life Sciences Corporation Information
11.10.2 LG Life Sciences Overview
11.10.3 LG Life Sciences Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.10.4 LG Life Sciences Pediatric Vaccines Products and Services
11.10.5 LG Life Sciences Pediatric Vaccines SWOT Analysis
11.10.6 LG Life Sciences Recent Developments
11.11 Lupin
11.11.1 Lupin Corporation Information
11.11.2 Lupin Overview
11.11.3 Lupin Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.11.4 Lupin Pediatric Vaccines Products and Services
11.11.5 Lupin Recent Developments
11.12 S K Chemicals
11.12.1 S K Chemicals Corporation Information
11.12.2 S K Chemicals Overview
11.12.3 S K Chemicals Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.12.4 S K Chemicals Pediatric Vaccines Products and Services
11.12.5 S K Chemicals Recent Developments
11.13 Mitsubishi Tanabe Pharma
11.13.1 Mitsubishi Tanabe Pharma Corporation Information
11.13.2 Mitsubishi Tanabe Pharma Overview
11.13.3 Mitsubishi Tanabe Pharma Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.13.4 Mitsubishi Tanabe Pharma Pediatric Vaccines Products and Services
11.13.5 Mitsubishi Tanabe Pharma Recent Developments
11.14 Janssen
11.14.1 Janssen Corporation Information
11.14.2 Janssen Overview
11.14.3 Janssen Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.14.4 Janssen Pediatric Vaccines Products and Services
11.14.5 Janssen Recent Developments
11.15 Shenzhen Kangtai Biological Products
11.15.1 Shenzhen Kangtai Biological Products Corporation Information
11.15.2 Shenzhen Kangtai Biological Products Overview
11.15.3 Shenzhen Kangtai Biological Products Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.15.4 Shenzhen Kangtai Biological Products Pediatric Vaccines Products and Services
11.15.5 Shenzhen Kangtai Biological Products Recent Developments
11.16 Sinovac Biotech
11.16.1 Sinovac Biotech Corporation Information
11.16.2 Sinovac Biotech Overview
11.16.3 Sinovac Biotech Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.16.4 Sinovac Biotech Pediatric Vaccines Products and Services
11.16.5 Sinovac Biotech Recent Developments
11.17 Bharat Biotech
11.17.1 Bharat Biotech Corporation Information
11.17.2 Bharat Biotech Overview
11.17.3 Bharat Biotech Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.17.4 Bharat Biotech Pediatric Vaccines Products and Services
11.17.5 Bharat Biotech Recent Developments
11.18 Crucell
11.18.1 Crucell Corporation Information
11.18.2 Crucell Overview
11.18.3 Crucell Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.18.4 Crucell Pediatric Vaccines Products and Services
11.18.5 Crucell Recent Developments
11.19 Dynavax
11.19.1 Dynavax Corporation Information
11.19.2 Dynavax Overview
11.19.3 Dynavax Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.19.4 Dynavax Pediatric Vaccines Products and Services
11.19.5 Dynavax Recent Developments
11.20 Serum Institute of India
11.20.1 Serum Institute of India Corporation Information
11.20.2 Serum Institute of India Overview
11.20.3 Serum Institute of India Pediatric Vaccines Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.20.4 Serum Institute of India Pediatric Vaccines Products and Services
11.20.5 Serum Institute of India Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pediatric Vaccines Value Chain Analysis
12.2 Pediatric Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pediatric Vaccines Production Mode & Process
12.4 Pediatric Vaccines Sales and Marketing
12.4.1 Pediatric Vaccines Sales Channels
12.4.2 Pediatric Vaccines Distributors
12.5 Pediatric Vaccines Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Pediatric Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Diphtheria
Table 3. Major Manufacturers of Influenza
Table 4. Major Manufacturers of Hepatitis
Table 5. Major Manufacturers of Pneumococcal Diseases
Table 6. Major Manufacturers of Meningococcal Diseases
Table 7. Major Manufacturers of Others
Table 8. Global Pediatric Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Pediatric Vaccines Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 10. Global Pediatric Vaccines Sales by Region (2017-2022) & (K Units)
Table 11. Global Pediatric Vaccines Sales Market Share by Region (2017-2022)
Table 12. Global Pediatric Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Pediatric Vaccines Revenue Market Share by Region (2017-2022)
Table 14. Global Pediatric Vaccines Sales Forecast by Region (2023-2028) & (K Units)
Table 15. Global Pediatric Vaccines Sales Market Share Forecast by Region (2023-2028)
Table 16. Global Pediatric Vaccines Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 17. Global Pediatric Vaccines Revenue Market Share Forecast by Region (2023-2028)
Table 18. Top Pediatric Vaccines Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 19. Pediatric Vaccines Market Trends
Table 20. Pediatric Vaccines Market Drivers
Table 21. Pediatric Vaccines Market Challenges
Table 22. Pediatric Vaccines Market Restraints
Table 23. Global Pediatric Vaccines Sales by Manufacturers (2017-2022) & (K Units)
Table 24. Global Pediatric Vaccines Sales Share by Manufacturers (2017-2022)
Table 25. Global Pediatric Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 26. Ranking of Global Top Pediatric Vaccines Manufacturers by Revenue (US$ Million) in 2021
Table 27. Pediatric Vaccines Revenue Share by Manufacturers (2017-2022)
Table 28. Global Pediatric Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pediatric Vaccines as of 2021)
Table 30. Key Manufacturers Pediatric Vaccines Average Selling Price (ASP) & (2017-2022) & (USD/Unit)
Table 31. Key Manufacturers Pediatric Vaccines Plants/Factories Distribution
Table 32. Key Manufacturers Pediatric Vaccines Area Served
Table 33. Date of Key Manufacturers Enter into Pediatric Vaccines Market
Table 34. Key Manufacturers Pediatric Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Pediatric Vaccines Sales (K Units) by Type (2017-2022)
Table 37. Global Pediatric Vaccines Sales Share by Type (2017-2022)
Table 38. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Type (2017-2022)
Table 39. Global Pediatric Vaccines Price (K Units) by Type (2017-2022)
Table 40. Global Pediatric Vaccines Sales (K Units) by Type (2023-2028)
Table 41. Global Pediatric Vaccines Sales Share by Type (2023-2028)
Table 42. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Type (2023-2028)
Table 43. Global Pediatric Vaccines Revenue Share by Type (2023-2028)
Table 44. Global Pediatric Vaccines Price (K Units) by Type (2023-2028)
Table 45. Global Pediatric Vaccines Sales (K Units) by Application (2017-2022)
Table 46. Global Pediatric Vaccines Sales Share by Application (2017-2022)
Table 47. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Application (2017-2022)
Table 48. Global Pediatric Vaccines Price (K Units) by Application (2017-2022)
Table 49. Global Pediatric Vaccines Sales (K Units) by Application (2023-2028)
Table 50. Global Pediatric Vaccines Sales Share by Application (2023-2028)
Table 51. Global Pediatric Vaccines Revenue (US$ Million) Market Share by Application (2023-2028)
Table 52. Global Pediatric Vaccines Revenue Share by Application (2023-2028)
Table 53. Global Pediatric Vaccines Price (K Units) by Application (2023-2028)
Table 54. North America Pediatric Vaccines Sales by Company (2017-2022) & (K Units)
Table 55. North America Pediatric Vaccines Sales Market Share by Company (2017-2022)
Table 56. North America Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 57. North America Pediatric Vaccines Revenue Market Share by Company (2017-2022)
Table 58. North America Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 59. North America Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 60. North America Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 61. North America Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 62. North America Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 63. North America Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 64. North America Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 65. North America Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 66. North America Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 67. North America Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 68. North America Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 69. North America Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 70. Europe Pediatric Vaccines Sales by Company (2017-2022) & (K Units)
Table 71. Europe Pediatric Vaccines Sales Market Share by Company (2017-2022)
Table 72. Europe Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 73. Europe Pediatric Vaccines Revenue Market Share by Company (2017-2022)
Table 74. Europe Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 75. Europe Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 76. Europe Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 77. Europe Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 78. Europe Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 79. Europe Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 80. Europe Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 81. Europe Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 82. Europe Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 83. Europe Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 84. Europe Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 85. Europe Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 86. Asia Pacific Pediatric Vaccines Sales by Company (2017-2022) & (K Units)
Table 87. Asia Pacific Pediatric Vaccines Sales Market Share by Company (2017-2022)
Table 88. Asia Pacific Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 89. Asia Pacific Pediatric Vaccines Revenue Market Share by Company (2017-2022)
Table 90. Asia Pacific Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 91. Asia Pacific Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 92. Asia Pacific Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 93. Asia Pacific Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 94. Asia Pacific Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 95. Asia Pacific Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 96. Asia Pacific Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 97. Asia Pacific Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 98. Asia Pacific Pediatric Vaccines Sales by Region (2017-2022) & (K Units)
Table 99. Asia Pacific Pediatric Vaccines Sales by Region (2023-2028) & (K Units)
Table 100. Asia Pacific Pediatric Vaccines Revenue by Region (2017-2022) & (US$ Million)
Table 101. Asia Pacific Pediatric Vaccines Revenue by Region (2023-2028) & (US$ Million)
Table 102. Latin America Pediatric Vaccines Sales by Company (2017-2022) & (K Units)
Table 103. Latin America Pediatric Vaccines Sales Market Share by Company (2017-2022)
Table 104. Latin America Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 105. Latin America Pediatric Vaccines Revenue Market Share by Company (2017-2022)
Table 106. Latin America Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 107. Latin America Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 108. Latin America Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 109. Latin America Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 110. Latin America Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 111. Latin America Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 112. Latin America Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 113. Latin America Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 114. Latin America Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 115. Latin America Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 116. Latin America Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 117. Latin America Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 118. Middle East and Africa Pediatric Vaccines Sales by Company (2017-2022) & (K Units)
Table 119. Middle East and Africa Pediatric Vaccines Sales Market Share by Company (2017-2022)
Table 120. Middle East and Africa Pediatric Vaccines Revenue by Company (2017-2022) & (US$ Million)
Table 121. Middle East and Africa Pediatric Vaccines Revenue Market Share by Company (2017-2022)
Table 122. Middle East and Africa Pediatric Vaccines Sales by Type (2017-2022) & (K Units)
Table 123. Middle East and Africa Pediatric Vaccines Sales by Type (2023-2028) & (K Units)
Table 124. Middle East and Africa Pediatric Vaccines Revenue by Type (2017-2022) & (US$ Million)
Table 125. Middle East and Africa Pediatric Vaccines Revenue by Type (2023-2028) & (US$ Million)
Table 126. Middle East and Africa Pediatric Vaccines Sales by Application (2017-2022) & (K Units)
Table 127. Middle East and Africa Pediatric Vaccines Sales by Application (2023-2028) & (K Units)
Table 128. Middle East and Africa Pediatric Vaccines Revenue by Application (2017-2022) & (US$ Million)
Table 129. Middle East and Africa Pediatric Vaccines Revenue by Application (2023-2028) & (US$ Million)
Table 130. Middle East and Africa Pediatric Vaccines Sales by Country (2017-2022) & (K Units)
Table 131. Middle East and Africa Pediatric Vaccines Sales by Country (2023-2028) & (K Units)
Table 132. Middle East and Africa Pediatric Vaccines Revenue by Country (2017-2022) & (US$ Million)
Table 133. Middle East and Africa Pediatric Vaccines Revenue by Country (2023-2028) & (US$ Million)
Table 134. GlaxoSmithKline Corporation Information
Table 135. GlaxoSmithKline Description and Overview
Table 136. GlaxoSmithKline Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 137. GlaxoSmithKline Pediatric Vaccines Product and Services
Table 138. GlaxoSmithKline Pediatric Vaccines SWOT Analysis
Table 139. GlaxoSmithKline Recent Developments
Table 140. Merck Corporation Information
Table 141. Merck Description and Overview
Table 142. Merck Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 143. Merck Pediatric Vaccines Product and Services
Table 144. Merck Pediatric Vaccines SWOT Analysis
Table 145. Merck Recent Developments
Table 146. Pfizer Corporation Information
Table 147. Pfizer Description and Overview
Table 148. Pfizer Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 149. Pfizer Pediatric Vaccines Product and Services
Table 150. Pfizer Pediatric Vaccines SWOT Analysis
Table 151. Pfizer Recent Developments
Table 152. Sanofi Corporation Information
Table 153. Sanofi Description and Overview
Table 154. Sanofi Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 155. Sanofi Pediatric Vaccines Product and Services
Table 156. Sanofi Pediatric Vaccines SWOT Analysis
Table 157. Sanofi Recent Developments
Table 158. AstraZeneca Corporation Information
Table 159. AstraZeneca Description and Overview
Table 160. AstraZeneca Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 161. AstraZeneca Pediatric Vaccines Product and Services
Table 162. AstraZeneca Pediatric Vaccines SWOT Analysis
Table 163. AstraZeneca Recent Developments
Table 164. Novartis Corporation Information
Table 165. Novartis Description and Overview
Table 166. Novartis Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 167. Novartis Pediatric Vaccines Product and Services
Table 168. Novartis Pediatric Vaccines SWOT Analysis
Table 169. Novartis Recent Developments
Table 170. Takeda Pharmaceutical Corporation Information
Table 171. Takeda Pharmaceutical Description and Overview
Table 172. Takeda Pharmaceutical Pediatric Vaccines Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022)
Table 173. Takeda Pharmaceutical Pediatric Vaccines Product and Services
Table 174. Takeda Pharmaceutical Pediatric Vaccines SWOT Analysis
Table 175. Takeda Pharmaceutical Recent Developments
Table 176. Bavarian Nordic Corporation Information
Table 177. Bavarian Nordic Description and Overview
Tabl
  • Global Albumin (as Excipient) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 114
    Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, t......
  • Global Bendamustine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 106
    Bendamustine is a chemotherapy medication used in the treatment of chronic lymphocytic leukemia (CLL), multiple myeloma, and non-Hodgkin's lymphoma. It is given by injection into a vein. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Bendamustine market is projected to reach US$ 743.1 million by 2028 from an estimated US$ 784.6 million in 2022, at a CAGR of -0.9% during 2023 and 2028. Market competition is inte......
  • Global Mitomycin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Mitomycin is an antibiotic which acts as a double-stranded DNA alkylating agent. It covalently crosslinks DNA, inhibiting DNA synthesis and cell proliferation It acts by way of reductive activation either through low pH or NAD(P)H:quinone oxidoreductase (DT-diaphorase) or NADH cytochrome c reductase (Mao et al.; Cummings et al.). Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Mitomycin market is projected to reach US$......
  • Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 104
    Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent. ......
  • Global Sevoflurane (Sevoflurane Source) Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 98
    Sevoflurane is a halogenated general inhalation anesthetic drug. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Sevoflurane (Sevoflurane Source) market is projected to reach US$ 1276.4 million by 2028 from an estimated US$ 1315.4 million in 2022, at a CAGR of -0.5% during 2023 and 2028. The top 5 players was expected to reach at about 65% market share by 2020, in terms of the globle sevoflurane revenue. ......
  • Global Iloprost Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 76
    Iloprost is a drug used to treat pulmonary arterial hypertension (PAH), scleroderma, Raynaud's phenomenon and other diseases in which the blood vessels are constricted and blood can't flow to the tissues. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Iloprost Drugs market is projected to reach US$ 80 million by 2028 from an estimated US$ 88 million in 2022, at a CAGR of -1.6% during 2023 and 2028. North Americ......
  • Global Treprostinil Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 85
    Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Treprostinil Drugs market is projected to reach US$ 1570.4 million by 2028 from an estimated US$ 1292.5 million in 2022, at a CAGR of 3.3% during 2023 and 2028. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following......
  • Global Swine Reproductive and Respiratory Syndrome Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
    Published: 29-Sep-2022        Price: US 5900 Onwards        Pages: 126
    Swine reproductive and respiratory syndrome is an acute and highly contagious viral infection characterized by reproductive disorder and respiratory symptoms in pig population. Highlights Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Swine Reproductive and Respiratory Syndrome Vaccine market is projected to reach US$ 844.2 million by 2028 from an estimated US$ 471.4 million in 2022, at a CAGR of 10.2% during 2023 and 2028.......
  • Global Bio Implant Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 29-Sep-2022        Price: US 5600 Onwards        Pages: 132
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bio Implant manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publicat......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs